Retail Healthcare Sector

Target Group

Market Cap: US$1.0m

Target Group Inc. cultivates, processes, and distributes curated cannabis products for the medical and adult-use recreational cannabis market in Canada and the United States.

Body and Mind

Market Cap: US$1.0m

Body and Mind Inc. cultivates, processes, distributes, and retails medical and recreational cannabis in Nevada, California, Arkansas, Ohio, Illinois, and New Jersey in the United States.

Evofem Biosciences

Market Cap: US$1.0m

A biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health.

AXM Pharma

Market Cap: US$1.0m

Manufactures and sells over-the-counter and prescription pharmaceutical products in the People's Republic of China.

Entheon Biomedical

Market Cap: CA$1.5m

Operates as a biotechnology research and development company.

MindBio Therapeutics

Market Cap: CA$1.4m

Operates as a clinical stage drug development company in Australasia.

TruSpine Technologies

Market Cap: UK£765.1k

A medical device company, engages in the development of spinal stabilization products in the United Kingdom and the United States.

Braxia Scientific

Market Cap: CA$1.4m

Operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders.

Terranueva

Market Cap: CA$1.4m

Terranueva Corporation intends to produce cannabis for medical and recreational purposes.

Psyence Group

Market Cap: CA$1.4m

A life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom.

Street Capital

Market Cap: CA$1.4m

Focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.

Vaxil Bio

Market Cap: CA$1.4m

A biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer.

SETO Holdings

Market Cap: US$994.9k

A development stage company, provides healthcare services.

Bluejay Diagnostics

Market Cap: US$991.7k

Operates as a medical diagnostics company.

Odyssey Health

Market Cap: US$986.4k

A medical company, focuses on the development and acquisition of medical related products.

Justera Health

Market Cap: CA$1.4m

Operates as a health and wellness management company in Canada.

BPH Global

Market Cap: AU$1.5m

Engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia.

Access-Power

Market Cap: US$948.2k

A medical marijuana clone company, manufactures and distributes medical marijuana clone products.

Syros Pharmaceuticals

Market Cap: US$946.1k

A biopharmaceutical company, focuses on the development of treatment for hematologic malignancies.

Wellfully

Market Cap: AU$1.5m

Wellfully Limited, together with its subsidiaries, focuses on the development and commercialization of Dermaportation and ETP transdermal drug delivery technologies.

UA Multimedia

Market Cap: US$937.9k

A media company, engages in Web, mobile applications, and film production and distribution activities.

NanoVibronix

Market Cap: US$933.9k

Through its subsidiaries, focuses on non-invasive biological response-activating devices that target wound healing and pain therapy and can be administered at home, without the assistance of medical professionals.

Brain Scientific

Market Cap: US$932.0k

Brain Scientific Inc., a medtech company, provides neurology and motion products in the United States and internationally.

Acutus Medical

Market Cap: US$927.3k

Designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally.

Medical Care Technologies

Market Cap: US$926.8k

A development stage company, engages in opening and operating children’s integrated health and wellness centers in China.

WOWI

Market Cap: US$900.0k

An early-stage company, engages in the business of licensing technology and intellectual property to operators and businesses in the legal cannabis industry in the United States.

Emmaus Life Sciences

Market Cap: US$897.3k

A commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.

Plandaí Biotechnology

Market Cap: US$888.9k

Focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries.

Dynatronics

Market Cap: US$881.4k

A medical device company, designs, develops, manufactures, markets, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States, Asia, Latin America, the Middle East, and internationally.

International Stem Cell

Market Cap: US$880.5k

A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.

EV Biologics

Market Cap: US$880.4k

A biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics.

RushNet

Market Cap: US$876.8k

Provides laboratory diagnostic testing services.

Rimrock Gold

Market Cap: US$865.2k

Through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts.

RAMM Pharma

Market Cap: CA$1.2m

Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.

Panacea Life Sciences Holdings

Market Cap: US$849.0k

Operates as a holding company, develops, manufactures, research, produces, and distributes hemp-derived cannabinoid, functional mushroom, Kratom, plant-based ingredients, and nutraceutical products for consumers and pets.

SQZ Biotechnologies

Market Cap: US$825.8k

A clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions.